Zobrazeno 1 - 10
of 10
pro vyhledávání: '"T. Kevin Murphy"'
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Nocebo effects encompass negative responses to inert interventions in the research setting and negative outcomes with active treatments in the clinical research or practice settings, including new or worsening symptoms and adverse events, stemming fr
Externí odkaz:
https://doaj.org/article/940abec4ba0f48fcb0abeb4620a09283
Publikováno v:
The Clinical Journal of Pain. 28:609-614
Objective To determine the incidence and duration of response of clinically meaningful improvements with pregabalin across several key symptoms of fibromyalgia (FM). Methods This was a post hoc analysis of data from a multicenter, double-blind, place
Autor:
Lesley M. Arnold, Lynne Pauer, Danielle Petersel, Bernhardt Zeiher, Birol Emir, Gayle Scott, T. Kevin Murphy
Publikováno v:
Clinical Therapeutics. 34:1092-1102
Background Pain relief and an acceptable safety profile have been reported in randomized controlled trials (RCTs) of pregabalin in the treatment of fibromyalgia (FM) for up to 14 weeks. Objective To evaluate the safety profile and tolerability of pre
Publikováno v:
The Journal of Pain. 13:58-63
The qualities of chronic neuropathic pain (NeP) may be informative about the different mechanisms of pain. We previously developed a 2-factor model of NeP that described an underlying structure among sensory descriptors on the Short-Form McGill Pain
Publikováno v:
Current Medical Research and Opinion. 26:2411-2419
Postherpetic neuralgia and painful diabetic peripheral neuropathy are common chronic neuropathic pain conditions associated with sleep disturbances. Pregabalin is indicated in the treatment of neuropathic pain. The objective of this review is to summ
Publikováno v:
BMC Family Practice, Vol 11, Iss 1, p 85 (2010)
BMC Family Practice
BMC Family Practice
Background Older patients are typically underrepresented in clinical trials of medications for chronic pain. A post hoc analysis of multiple clinical studies of pregabalin in patients with painful diabetic peripheral neuropathy (DPN) or postherpetic
Publikováno v:
PainReferences. 152(5)
Pregabalin has demonstrated efficacy in several forms of neuropathic pain, but its long-term efficacy in central post-stroke pain (CPSP) is unproven. We evaluated the efficacy and safety of pregabalin versus placebo in patients with CPSP. A 13-week,
Autor:
T. Kevin Murphy, Brook Knight Morse, John W. Wong, Richard Gerald Wax, Hamish A. I. McArthur, Gagne John William, Adam A. Smogowicz, Matt H. Narrol, Maria S. Brown, David Austen Perry, Ellen L. McCormick
Publikováno v:
The Journal of Antibiotics. 50:698-700
Publikováno v:
Current Medical Research & Opinion; Oct2010, Vol. 26 Issue 10, p2411-2419, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.